Listen

Description

Bloomberg: $35/month. Financial Times: $42/month. The Economist: $17/month. Original analysis by Tatsu with 40+ footnotes: $8/month, 7-day free trial.

This post is public. Share it with anyone who should see this.

When you stand in front of an Eastern Orthodox icon, you think you are looking at the saint. The composition is built the other way around. Western painting since the Renaissance puts the vanishing point behind the panel, so your eye is the origin and the scene falls away from you into depth. An icon reverses the lines. They open outward, into the room, into the person standing there. The figure is looking out, not being studied. You did not come to examine the saint. You came to be seen by one.

Nathan Fielder's "You Can See Everything," 174 minutes, in theaters now and sitting at a near perfect critical score, is built like an icon.[1] Holmes approached A24 herself. She performs herself. Amanda Seyfried, who already won an Emmy playing her once, re-enacts her a second time, in front of her, while she watches. You buy a ticket believing you will finally settle what she is, and the film is arranged so the attention comes back the other way, out of the frame, onto you. Even the title is a tell. It never says who is doing the seeing.

While you sit there deciding whether she is a monster or a misguided girl, the thing the composition is quietly watching, past your shoulder, is a $452 million restitution judgment that will never be collected, and a clemency petition sitting in a pardon office that this year already freed a man whose signature innovation was rolling a truck down a hill. Her face is the misdirection. The money is the subject.

Milton Walked, Holmes Is Knocking

In March 2025, Donald Trump pardoned Trevor Milton, founder of the electric truck company Nikola, convicted in 2022 of securities and wire fraud.[2] One of the counts rested on a promotional video of a Nikola semi gliding down a desert highway. The truck did not run. It had been towed to the top of an incline and released, and gravity did the marketing. He was sentenced to four years. The pardon erased all of it, including roughly $168 million in restitution owed to the shareholders he deceived. Milton and his wife had given more than $1.8 million to a Trump fundraising vehicle in the weeks before the election. The pardon was the business model, not an outlier.

More than half of the individual pardons Trump has issued this term have gone to people convicted of white collar offenses, and the clemency has forgiven close to $1.7 billion in financial penalties that courts had ordered defendants to pay.[3] The beneficiaries include a man who ran a $1.6 billion fund fraud against more than ten thousand investors and a woman who was serving thirty-five years. Congress has held hearings with titles that amount to asking why the president keeps freeing fraudsters. The answer is not mysterious.

Elizabeth Holmes filed her own request in 2025. It became public in January 2026, listed as pending at the Office of the Pardon Attorney.[4] She is asking for a commutation, which would end her sentence early without erasing the conviction, and she has spent the run-up posting admiringly about the president. Her sentence has already been trimmed from 135 months to 123, and she is approved for transfer to a halfway house in the summer of 2027.[5] The documentary, the warm posts, the petition, and the countdown to release are one campaign, not four separate stories, and it is going reasonably well.

Four Counts, Zero Patients

The most misunderstood fact in the entire saga is what a jury actually decided. Holmes was tried on eleven counts. She was convicted on four, every one of them a species of lying to investors: one count of conspiracy and three counts of wire fraud tied to specific people who wrote checks.[6] She was found not guilty on all four counts that concerned patients, the people who got the bad blood results, and the jury hung on three more. A room of twelve citizens heard the patient-harm case in full and declined to find she had set out to defraud the sick. What she was convicted of is deceiving the wealthy.

That distinction matters, because the deception of investors is not in serious doubt and never was. When Pfizer and Schering-Plough declined to endorse Theranos devices, the company took their logos, pasted them onto validation reports those firms had never written, and handed the forgeries to investors and to Walgreens as independent proof.[7] On the stand, Holmes admitted it:

"I wish I'd done it differently."

You cannot accidentally forge another company's letterhead. It is a discrete, dated, deliberate act, and it is the center of the case. The patients, meanwhile, were harmed in a way the law found harder to pin on intent. A 2016 federal inspection of the Newark lab concluded that its failures posed, in the inspectors' own words,

"immediate jeopardy to patient health and safety."

Theranos ultimately voided or corrected two full years of results from its proprietary Edison machines, somewhere between fifty and sixty thousand tests.[8] People were told they were HIV positive who were not. Potassium readings came back at values that, if believed, describe a medical emergency.

The investors were a more glittering list than the patients ever were. Rupert Murdoch alone put in $125 million, the largest individual stake, and later sold the whole position back for a dollar.[9] He got a dollar more for it than the technology was ever worth.

$452 Million Is a Prop

After the convictions, Judge Edward Davila ordered Holmes and Balwani jointly to pay $452 million in restitution to their victims.[10] It is an enormous, serious, headline number, and everyone involved understood at the moment it was announced that it was theater.

While she is incarcerated, Holmes pays restitution at a rate of $25 per quarter.[11] That is one hundred dollars a year. Against $452 million, the judgment clears in roughly two and a quarter million years, which is patient capital even by the standards of the people she defrauded. After release, prosecutors sought a minimum of $250 a month from her, and her lawyers argued she could not manage even that. Balwani, who had real money before Theranos, was ordered to pay at least $1,000 a month.[12] Call it fifteen thousand dollars a year between them at perfect compliance, and the arithmetic improves to about thirty thousand years.

None of this is unusual, which is the part worth sitting with. Federal criminal restitution is, as a system, uncollectable by design. At the close of fiscal 2016, roughly $110 billion in ordered restitution was outstanding, and the government itself had already classified about $100 billion of it as uncollectible.[13] The collection rate runs under ten percent. The Justice Department's own estimate is that of that $110 billion, it will ever recover perhaps ten. The $452 million attached to Holmes is a number the system produces for the press release and then quietly files away, not a penalty she is evading. A commutation would not touch it, and neither would full payment at her own lawyers' proposed rate, because the rate was chosen to never arrive.

Independent, footnoted analysis like this takes a week of reading court filings and government audits so you do not have to. The day-by-day news stays free. What is below, the psychology the documentary cannot narrate and the machine that made all of it survivable, is the part worth eight dollars a month. Bloomberg wants thirty-five. The first week is free.

Start a 7-day free trial. The rest of the investigation, who she actually is and why none of it cost her, is below. $80/year if you stay, less than two Bloomberg sandwiches.

Arrested Development at Nineteen

Here is a theory the court was not equipped to test and the documentary is too careful to assert. Holmes left Stanford as a teenager, in her sophomore year, and something in her stopped developing at the age she left. At forty-two she still relates to other peop…



This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit tatsuikeda.substack.com/subscribe